Evidence map›Paper›PMID 41401348›Full record

Trial reportThe American journal of drug and alcohol abuse2025

Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone.

Azizi Ray, Michael J Mancino, Jeff D Thostenson, Joseph B Guise, Howard P Hendrickson, Edward V Nunes, Alison H Oliveto

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of drug and alcohol abuse, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Azizi RayDepartment of Pharmacy Practice and Administrative Sciences, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.ORCID 0000-0001-7784-3987
Michael J MancinoDepartment of Psychiatry and Behavioral Sciences, University of Arkansas for Medical Sciences, Little Rock, AR, USA.ORCID 0000-0002-7234-6305
Jeff D ThostensonDepartment of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.ORCID 0009-0003-9635-5729
Joseph B GuiseDepartment of Psychiatry and Behavioral Sciences, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Howard P HendricksonDepartment of Pharmaceutical, Social and Administrative Sciences, Samford University, Birmingham, AL, USA.ORCID 0000-0003-2151-5911
Edward V NunesDepartment of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA.ORCID 0000-0002-2055-3425
Alison H OlivetoDepartment of Psychiatry and Behavioral Sciences, University of Arkansas for Medical Sciences, Little Rock, AR, USA.ORCID 0000-0001-8574-230X

Funding

Expanding Translational Research in ArkansasUL1TR003107 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI JAMES, LAURA P · 2019 to 2023
$21.6M
Translational Training in AddictionT32DA022981 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI Melissa Jean Zielinski · 2009 to 2026
$6.1M
Mentoring Emerging Scientists for Careers in Substance Use ResearchR25DA035163 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Carmen L Masson, Gideon St.Helen · 2014 to 2026
$4.6M
Improving Treatment Outcomes for Prescription Opioid DependenceR01DA039088 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI MANCINO, MICHAEL J, OLIVETO, ALISON · 2015 to 2019
$2.9M
NCATS NIH HHS UL1 TR003107NIDA NIH HHS R01 DA036544-01ANIDA NIH HHS R01 DA039088NIDA NIH HHS R25 DA035163NIDA NIH HHS T32 DA022981NIDA NIH HHS UL1 TR003107T32
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BuprenorphineGabapentinNaltrexoneNarcotic AntagonistsOpiate Substitution TreatmentOpioid-Related DisordersSubstance Withdrawal SyndromeAdultDouble-Blind MethodFemaleHumansMaleMiddle AgedOutpatientsTreatment OutcomeBuprenorphineGabapentinNaltrexoneNarcotic Antagonistsbuprenorphine taperfentanylgabapentinnaltrexoneOpioid use disorder

Identifiers

PMID41401348
PMCPMC13618342

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.